23andme regeneron - Search News

Order byBest matchMost fresh

News

Regeneron buying 23andMe

Regeneron Acquires 23andMe in $256M Deal

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of accessible, genome-based health insights.

Continue reading

Medindia · 13m

Regeneron buying 23andMe; What happened to 23andMe? Should I delete 23andMe data?

· 4d · on MSN

Regeneron to buy 23andMe out of bankruptcy for $256 million

Predictive Oncology breakthrough coincides with Regeneron Pharma’s acquisition of 23andMe for $256 million: Artificial intelligence meets genomics

Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

2d

Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results